Stockscreener 앱 받기
0.4757
7.92%
-0.0423
전일 마감가:
$0.518
열려 있는:
$0.527
하루 거래량:
735.41K
Relative Volume:
2.15
시가총액:
$83.60M
수익:
$49.09M
순이익/손실:
$-52.15M
주가수익비율:
-0.7318
EPS:
-0.65
순현금흐름:
$-45.93M
1주 성능:
-16.71%
1개월 성능:
-16.37%
6개월 성능:
-64.40%
1년 성능:
-65.93%
1일 변동 폭
$0.4716
$0.527
1주일 범위
$0.4716
$0.5995
52주 변동 폭
$0.45
$2.04
바이오데식스 Stock (BDSX) Company Profile
명칭
Biodesix Inc
전화
303-417-0500
주소
919 WEST DILLON ROAD, LOUISVILLE
BDSX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BDSX
Biodesix Inc
|
0.4757 | 83.60M | 49.09M | -52.15M | -45.93M | -0.65 |
|
TMO
Thermo Fisher Scientific Inc
|
423.56 | 159.05B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
199.05 | 140.21B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
478.45 | 35.17B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
109.18 | 30.47B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
153.84 | 26.47B | 15.41B | 1.37B | 2.11B | 7.50 |
바이오데식스 Stock (BDSX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-09-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-07-26 | 개시 | Craig Hallum | Buy |
| 2024-05-13 | 개시 | TD Cowen | Buy |
| 2024-05-03 | 개시 | Lake Street | Buy |
| 2021-11-17 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-23 | 개시 | BTIG Research | Buy |
| 2020-11-23 | 개시 | Canaccord Genuity | Buy |
| 2020-11-23 | 개시 | Morgan Stanley | Overweight |
| 2020-11-23 | 개시 | William Blair | Outperform |
모두보기
바이오데식스 주식(BDSX)의 최신 뉴스
Biodesix, Inc. (NASDAQ:BDSX) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) Shares Purchased by Renaissance Technologies LLC - Defense World
Canaccord Genuity Group Has Lowered Expectations for Biodesix (NASDAQ:BDSX) Stock Price - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) Receives $2.95 Average Target Price from Analysts - Defense World
Geode Capital Management LLC Increases Position in Biodesix, Inc. (NASDAQ:BDSX) - Defense World
Canaccord Genuity Group Lowers Biodesix (NASDAQ:BDSX) Price Target to $2.50 - Defense World
Biodesix (BDSX) Target Price Reduced by Canaccord Amid Market Ch - GuruFocus
Wells Fargo & Company MN Has $1.28 Million Holdings in Biodesix, Inc. (NASDAQ:BDSX) - Defense World
Biodesix to Report First Quarter 2025 Financial Results on May 1 - GuruFocus
Biodesix, Inc. to Release First Quarter 2025 Financial Results on May 13 - Nasdaq
Biodesix to Report First Quarter 2025 Financial Results on May 13, 2025 - Bluefield Daily Telegraph
Biodesix to Report First Quarter 2025 Financial Results on May 13, 2025 - GlobeNewswire Inc.
Biodesix and Bio-Rad Drive Advances in ctDNA-Based Cancer Therapies - Technology Networks
Ratios Uncovered: Breaking Down Biodesix Inc (BDSX)’s Trailing Twelve Months Metrics - DWinneX
Silverarc Capital Management LLC Acquires 771,187 Shares of Biodesix, Inc. (NASDAQ:BDSX) - MarketBeat
Biodesix Inc (BDSX) Stock: From Low to High in 52 Weeks - investchronicle.com
Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types - MSN
Biodesix Inc [BDSX] Chief Accounting Officer makes an insider purchase of 3,630 shares worth 3355.0. - knoxdaily.com
Biodesix and Bio-Rad publish data linking ctDNA changes to treatment outcomes in solid tumors - Select Science
Is Biodesix Inc (BDSX) worth investing in despite its overvalued state? - uspostnews.com
Market Resilience: Biodesix Inc (BDSX) Finishes Weak at 0.49, Down -2.00 - DWinneX
Biodesix partner, Friends of Cancer Research, publishes data in - GuruFocus
Biodesix and Bio-Rad Laboratories Collaborate on Research Revealing ctDNA's Role in Cancer Treatment Outcomes - Nasdaq
Major Clinical Trial Proves ctDNA Testing Accurately Predicts Cancer Treatment Outcomes in Breakthrough Study - Stock Titan
Investors Give Biodesix, Inc. (NASDAQ:BDSX) Shares A 33% Hiding - simplywall.st
Biodesix Announces Board Member Resignations - TipRanks
Biodesix, Inc. Announces Director and Committee Resignations - marketscreener.com
Samjo Management LLC Makes New Investment in Biodesix, Inc. (NASDAQ:BDSX) - MarketBeat
Biodesix Inc [BDSX] stock was sold by Vazquez Chris at the price of US$3355.0 - knoxdaily.com
Biodesix, Inc. (NASDAQ:BDSX) Short Interest Up 29.5% in March - MarketBeat
HighTower Advisors LLC Acquires 22,500 Shares of Biodesix, Inc. (NASDAQ:BDSX) - Defense World
AIGH Capital Management LLC Buys 500,000 Shares of Biodesix, Inc. (NASDAQ:BDSX) - MarketBeat
Closing Figures Unveiled: Biodesix Inc (BDSX) Drop -3.06, Closes at 0.61 - DWinneX
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
BDSX stock touches 52-week low at $0.63 amid market challenges - Investing.com
Perkins Capital Management Inc. Purchases 335,429 Shares of Biodesix, Inc. (NASDAQ:BDSX) - MarketBeat
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Biodesix, Inc. (NASDAQ:BDSX) Short Interest Update - MarketBeat
Biodesix Completes Enrollment of INSIGHT Study Assessing Clinical Utility of the VeriStrat® Blood-Based Host Immune Classifier - Business Wire
Biodesix, Inc. (NASDAQ:BDSX) Short Interest Up 24.6% in February - Defense World
Biodesix to Present at Cowen’s 42nd Annual Healthcare Conference - Business Wire
Biodesix chief commercial officer sells shares worth $16,198 - MSN
Q1 Earnings Estimate for Biodesix Issued By William Blair - MarketBeat
바이오데식스 (BDSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.15%
자본화:
|
볼륨(24시간):